Annual Cash & Cash Equivalents
$32.63 M
+$26.69 M+449.86%
December 31, 2023
Summary
- As of February 7, 2025, COYA annual cash & cash equivalents is $32.63 million, with the most recent change of +$26.69 million (+449.86%) on December 31, 2023.
- During the last 3 years, COYA annual cash & cash equivalents has risen by +$23.91 million (+274.13%).
- COYA annual cash & cash equivalents is now at all-time high.
Performance
COYA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$31.06 M
-$5.52 M-15.09%
September 30, 2024
Summary
- As of February 7, 2025, COYA quarterly cash and cash equivalents is $31.06 million, with the most recent change of -$5.52 million (-15.09%) on September 30, 2024.
- Over the past year, COYA quarterly cash and cash equivalents has increased by +$20.17 million (+185.29%).
- COYA quarterly cash and cash equivalents is now -15.09% below its all-time high of $36.58 million, reached on June 30, 2024.
Performance
COYA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COYA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +449.9% | +185.3% |
| 3 y3 years | +274.1% | +259.0% |
| 5 y5 years | +274.1% | +259.0% |
COYA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +651.7% | -15.1% | +615.6% |
| 5 y | 5-year | at high | +651.7% | -15.1% | +615.6% |
| alltime | all time | at high | +651.7% | -15.1% | +615.6% |
Coya Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.06 M(-15.1%) |
| Jun 2024 | - | $36.58 M(+1.6%) |
| Mar 2024 | - | $35.99 M(+10.3%) |
| Dec 2023 | $32.63 M | $32.63 M(+199.7%) |
| Sep 2023 | - | $10.89 M(-16.9%) |
| Jun 2023 | - | $13.10 M(-19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $16.32 M(+175.0%) |
| Dec 2022 | $5.93 M(+36.7%) | $5.93 M(-31.4%) |
| Sep 2022 | - | $8.65 M(+99.3%) |
| Dec 2021 | $4.34 M(-50.2%) | - |
| Dec 2021 | - | $4.34 M |
| Dec 2020 | $8.72 M | - |
FAQ
- What is Coya Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Coya Therapeutics?
- What is Coya Therapeutics annual cash & cash equivalents year-on-year change?
- What is Coya Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Coya Therapeutics?
- What is Coya Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Coya Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of COYA is $32.63 M
What is the all time high annual cash & cash equivalents for Coya Therapeutics?
Coya Therapeutics all-time high annual cash & cash equivalents is $32.63 M
What is Coya Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, COYA annual cash & cash equivalents has changed by +$26.69 M (+449.86%)
What is Coya Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of COYA is $31.06 M
What is the all time high quarterly cash and cash equivalents for Coya Therapeutics?
Coya Therapeutics all-time high quarterly cash and cash equivalents is $36.58 M
What is Coya Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, COYA quarterly cash and cash equivalents has changed by +$20.17 M (+185.29%)